Recent treatment of bronchial asthma.doc

 PAGE \* MERGEFORMAT 8 Recent treatment of bronchial asthma [Keywords:] Recent bronchial asthma treatment Bronchial asthma (the asthma) is a common respiratory disease. Clinically, with repeated episodes of wheezing, shortness of breath, chest tightness or cough, its main features. Has been confirmed that Asthma is a chronic non-specific airway inflammation, is a combination of inflammatory cells, inflammatory mediators and cytokines are involved in the inflammatory process [1], is the treatment of bronchial asthma on the current situation are summarized below. A glucocorticoid Glucocorticoid is currently the most effective drugs against the disease [2], route of administration, including inhalation, oral and intravenous application, inhalation is the preferred way. 1.1 Local inhaled corticosteroid inhalation resistance is stronger, drug directly on the respiratory tract, the required dose of smaller, research and development in recent years, emphasizing the early use of steroids, particularly the widespread promotion of inhaled drugs [3], dose is small, very few adverse reactions have been listed in the inhaled steroid fluticasone propionate and budesonide minimal systemic adverse reactions. There is evidence that adult asthma patients in a daily low dose of inhaled steroid, does not appear significant systemic adverse reactions. Oral administration of 1.2 for moderate asthma attacks, chronic persistent asthma, high-dose inhaled corticosteroid combination therapy in patients with ineffective and as a hormone therapy after intravenous application of sequential therapy, the general use of shorter half-life of hormones (such as prednisone, throwing Nepal Song Long, methylprednisolone, etc.), recommended dose: prednisone 30 ~ 50mg / d, 5 ~ 10 days, the specific use according to the severity of illness, when the relief of symptoms or their lung function has been to achieve their personal best value, can be considered withdrawal or reduction. 1.3 intravenous